This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Infinity Pharmaceuticals Inc
INFI : NASDAQ : Health Care
$15.84 0.04 | 0.25%
Today's Range: 15.57 - 16.12
Avg. Daily Volume: 761,600
01/27/15 - 4:00 PM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
INFI INFINITY PHARMACEUTICALS INC 14.73 718.34 n/m 160.64 n/a
RGLS REGULUS THERAPEUTICS INC 18.26 887.51 n/m 8.90 -48.69
ENTA ENANTA PHARMACEUTICALS INC 46.00 856.29 26.14 47.74 1038.31
BCRX BIOCRYST PHARMACEUTICALS INC 10.70 768.94 n/m 18.73 72.37
ZIOP ZIOPHARM ONCOLOGY INC 7.34 753.90 n/m 1.23 54.12
FOLD AMICUS THERAPEUTICS INC 7.96 741.14 n/m 1.55 3869.23
AEGR AEGERION PHARMACEUTICALS INC 24.51 696.97 n/m 131.16 445.32
OMED ONCOMED PHARMACEUTICALS 22.72 677.78 n/m 50.03 94.46
RNA PROSENSA HOLDING NV 18.76 677.54 n/m 23.16 263.21
EPZM EPIZYME INC 19.59 669.25 n/m 67.38 109.47
ARRY ARRAY BIOPHARMA INC 5.05 666.41 n/m 33.92 -50.11
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

INFI Ind Avg S&P 500
n/m 83.11 19.47
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs